WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007000463) NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/000463    International Application No.:    PCT/EP2006/063631
Publication Date: 04.01.2007 International Filing Date: 28.06.2006
IPC:
C07D 471/10 (2006.01), A61K 31/438 (2006.01), A61P 25/00 (2006.01)
Applicants: NeuroSearch A/S [DK/DK]; 93 Pederstrupvej, DK-2750 Ballerup (DK) (For All Designated States Except US).
ERIKSEN, Birgitte, L. [DK/DK]; (DK) (For US Only).
PETERS, Dan [SE/DK]; (DK) (For US Only).
NIELSEN, Elsebet, Østergaard [DK/DK]; (DK) (For US Only).
REDROBE, John Paul [GB/DK]; (DK) (For US Only)
Inventors: ERIKSEN, Birgitte, L.; (DK).
PETERS, Dan; (DK).
NIELSEN, Elsebet, Østergaard; (DK).
REDROBE, John Paul; (DK)
Common
Representative:
NeuroSearch A/S; Patent Department, 93 Pederstrupvej, DK-2750 Ballerup (DK)
Priority Data:
PA 2005 00960 28.06.2005 DK
60/694,678 29.06.2005 US
Title (EN) NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
(FR) NOUVEAUX DERIVES 3,9-DIAZA-SPIRO[5.5]UNDECANE ET LEUR UTILISATIN EN TANT QU’INHIBITEURS DU RECAPTAGE DU NEUROTRANSMITTEUR MONOAMINE
Abstract: front page image
(EN)This invention relates to novel 3,9-diaza-spiro[5.5]undecane derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
(FR)La présente invention concerne de nouveaux dérivés 3,9-diaza-spiro[5.5]undécane utiles en tant qu’inhibiteurs du recaptage du neurotransmetteur monoamine. D’autres aspects de l’invention concernent l’utilisation de ces composés dans le cadre d’un procédé de traitement ainsi que des compositions pharmaceutiques comprenant les composés selon l’invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)